Epernicus: Judy J Chang, Ph.D.

Judy J Chang, Ph.D.

Position:
Post Doctoral Fellow

Ragon Institute of MGH, MIT and Harvard

Massachusetts General Hospital (Boston, MA)
Advisor:
Marcus Altfeld
Degrees:

Ph.D., Microbiology and Immunology, University of Melbourne (Melbourne, Australia)

B.Sc., Microbiology and Immunology, University of Melbourne (Melbourne, Australia)
Past Advisors:
Research:

Communities:

Judy Chang's Genealogy

The Adobe Flash Player plugin (version 8) is required to view the genealogy tree.
Download the plugin here.

Judy Chang's Publications (14)

Innate immune activation in primary HIV-1 infection.
Chang JJ, Altfeld M

The Journal of infectious diseases. 2010 Oct 15;202 Suppl 2:S297-301
Exposure to HIV-1-encoded Toll-like receptor 8 ligands enhances monocyte response to microbial encoded Toll-like receptor 2/4 ligands.
Mureith MW, Chang JJ, Lifson JD, Ndung'u T, Altfeld M

AIDS (London, England). 2010 Jul 31;24(12):1841-8
No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy.
Crane M, Sirivichayakul S, Chang JJ, Avihingsanon A, Ubolyam S, Buranapraditkun S, Thantiworasit P, Wightman F, Locarnini S, Matthews G, Dore GJ, Ruxrungtham K, Lewin SR

Journal of virology. 2010 Mar;84(6):2657-65
Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand.
Avihingsanon A, Lewin SR, Kerr S, Chang JJ, Piyawat K, Napissanant N, Matthews GV, Dore GJ, Bowden S, Lange J, Ruxrungtham K

Antiviral therapy. 2010;15(6):917-22
Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection.
Chang JJ, Sirivichayakul S, Avihingsanon A, Thompson AJ, Revill P, Iser D, Slavin J, Buranapraditkun S, Marks P, Matthews G, Cooper DA, Kent SJ, Cameron PU, Sasadeusz J, Desmond P, Locarnini S, Dore GJ, Ruxrungtham K, Lewin SR

Journal of virology. 2009 Aug;83(15):7649-58
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.
Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, Wen TF, Lindsay RJ, Orellana L, Mildvan D, Bazner S, Streeck H, Alter G, Lifson JD, Carrington M, Bosch RJ, Robbins GK, Altfeld M

Nature medicine. 2009 Aug;15(8):955-9
Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy.
Crane M, Oliver B, Matthews G, Avihingsanon A, Ubolyam S, Markovska V, Chang JJ, Dore GJ, Price P, Visvanathan K, French M, Ruxrungtham K, Lewin SR

The Journal of infectious diseases. 2009 Apr 1;199(7):974-81
TLR-mediated immune activation in HIV.
Chang JJ, Altfeld M

Blood. 2009 Jan 8;113(2):269-70
Rapid loss of dendritic cell and monocyte responses to TLR ligands following venipuncture.
Meier A, Fisher A, Sidhu HK, Chang JJ, Wen TF, Streeck H, Alter G, Silvestri G, Altfeld M

Journal of immunological methods. 2008 Dec 31;339(2):132-40
The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection.
Chang JJ, Thompson AJ, Visvanathan K, Kent SJ, Cameron PU, Wightman F, Desmond P, Locarnini SA, Lewin SR

Hepatology (Baltimore, Md.). 2007 Nov;46(5):1332-40
Immunopathogenesis of hepatitis B virus infection.
Chang JJ, Lewin SR

Immunology and cell biology. 2007 Jan;85(1):16-23
Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein.
Visvanathan K, Skinner NA, Thompson AJ, Riordan SM, Sozzi V, Edwards R, Rodgers S, Kurtovic J, Chang J, Lewin S, Desmond P, Locarnini S

Hepatology (Baltimore, Md.). 2007 Jan;45(1):102-10
Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.
Chang JJ, Wightman F, Bartholomeusz A, Ayres A, Kent SJ, Sasadeusz J, Lewin SR

Journal of virology. 2005 Mar;79(5):3038-51
Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis B virus YMDD variant in an HIV/hepatitis B virus-co-infected patient.
Gouskos T, Wightman F, Chang J, Earnest-Silveira L, Sasadeusz J, Lewin SR, Torresi J

AIDS (London, England). 2004 Aug 20;18(12):1734-7

Join Epernicus (membership is free)

Epernicus is open to current and former research scientists.

Already a member?
Sign in to view Judy's full profile.

Judy J Chang, Ph.D.

Post Doctoral Fellow

Judy Chang's Genealogy

Judy Chang's Publications (14)